Se Hwan Yang

Title: Se Hwan Yang: Innovator in Medical Treatments

Introduction

Se Hwan Yang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical treatments, particularly in the area of anemia and immune response. With a total of five patents to his name, Yang's work is recognized for its innovative approaches to complex health issues.

Latest Patents

One of Yang's latest patents is a method of treating anemia using a long-acting EPO formulation. This invention focuses on a method for treating patients with anemia by confirming a safe, long-acting, and optimal effective dosage of a fusion polypeptide that combines EPO and an immunoglobulin hybrid Fc. The method aims to minimize cardiovascular side effects while providing an effective treatment for anemia. Another notable patent is for a modified interleukin-7 protein, which can be used in high yield and is biologically active in viral infection and cancer models. This innovation has potential applications in the prevention and treatment of various diseases.

Career Highlights

Throughout his career, Se Hwan Yang has worked with notable companies such as Genexine, Inc. and The Green Cross Corporation. His experience in these organizations has contributed to his expertise in developing advanced medical treatments.

Collaborations

Yang has collaborated with several professionals in his field, including Donghoon Choi and Hye Seong Lim. These collaborations have further enhanced his research and development efforts.

Conclusion

Se Hwan Yang is a distinguished inventor whose work in medical treatments has the potential to significantly impact patient care. His innovative patents reflect his commitment to advancing healthcare solutions.